These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16463553)

  • 1. [Ibandronate once a month].
    Polk B
    Med Monatsschr Pharm; 2006 Jan; 29(1):36-7. PubMed ID: 16463553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?].
    Kastelan D; Vlak T
    Reumatizam; 2007; 54(2):87-8. PubMed ID: 18351153
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous ibandronate (Boniva).
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):68-9. PubMed ID: 16977282
    [No Abstract]   [Full Text] [Related]  

  • 4. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract]   [Full Text] [Related]  

  • 5. Once-monthly ibandronate for postmenopausal osteoporosis: review of a new dosing regimen.
    Pyon EY
    Clin Ther; 2006 Apr; 28(4):475-90. PubMed ID: 16750461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment holidays in patients with postmenopausal osteoporosis: whom and when?
    Reyes García R; García Martín A; Muñoz-Torres M
    Endocrinol Nutr; 2012 Dec; 59(10):573-4. PubMed ID: 23031434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of postmenopausal osteoporosis in the general medical practice (clinical case)].
    Zhdan VM; Kitura OIe; Kitura IeM; Babanina MIu; Tkachenko MV
    Lik Sprava; 2013 Mar; (2):85-9. PubMed ID: 24605616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 9. Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.
    Cranney A; Wells GA; Yetisir E; Adami S; Cooper C; Delmas PD; Miller PD; Papapoulos S; Reginster JY; Sambrook PN; Silverman S; Siris E; Adachi JD
    Osteoporos Int; 2009 Feb; 20(2):291-7. PubMed ID: 18663402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single annual injectable treatment for postmenopausal osteoporosis.
    Chapurlat RD
    Expert Opin Drug Deliv; 2008 May; 5(5):583-91. PubMed ID: 18491983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Question: In postmenopausal women with osteoporosis is once monthly oral ibandronate (150 mg) therapy preferred to once weekly oral bisphosphonate therapy.
    Dave M; Criswell DF
    J Okla State Med Assoc; 2012 Mar; 105(3):89-90. PubMed ID: 22685920
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of bisphosphonates in the management of postmenopausal osteoporosis.
    Papapoulos SE
    Ann N Y Acad Sci; 2011 Feb; 1218():15-32. PubMed ID: 20946579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibandronate: the evolution of a once-a-month oral therapy for postmenopausal osteoporosis.
    Dempster DW; Bolognese MA
    J Clin Densitom; 2006; 9(1):58-65. PubMed ID: 16731432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibandronate and nonvertebral fracture efficacy: results of a recent pooled analysis.
    Sunyecz JA
    Phys Sportsmed; 2010 Jun; 38(2):183-5. PubMed ID: 20631479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monthly tablet in postmenopausal osteoporosis].
    Krankenpfl J; 2005; 43(7-10):216. PubMed ID: 16515288
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteoporosis priority: Reduce the number of fractures].
    Roux C
    Presse Med; 2006 Oct; 35(10 Pt 2):1527-8. PubMed ID: 17028516
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis.
    Felsenberg D; Miller P; Armbrecht G; Wilson K; Schimmer RC; Papapoulos SE
    Bone; 2005 Nov; 37(5):651-4. PubMed ID: 16126016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal Osteoporosis.
    Cheung AM; Papaioannou A; Morin S;
    N Engl J Med; 2016 May; 374(21):2096. PubMed ID: 27223160
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal Osteoporosis.
    Ott SM
    N Engl J Med; 2016 May; 374(21):2095-6. PubMed ID: 27223159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.